FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan

      Mizuho Lowers Price Target for Boston Scientific Ahead of Earnings Report

      Mizuho has adjusted its price target for Boston Scientific Corporation, reducing it from $115 to $90 while maintaining an Outperform rating. This change comes as the company prepares to release its first-quarter earnings for the medical device sector.

      Boston Scientific is recognized as one of the top healthcare stocks to buy and hold for a three-year period, according to a recent compilation. The company's performance in the upcoming earnings report will be closely watched by investors and analysts alike.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud